These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1069 related articles for article (PubMed ID: 9636688)

  • 21. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
    Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA
    Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
    Koulova L; Yang SY; Dupont B
    J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.
    Martinez OM; Gibbons RS; Garovoy MR; Aronson FR
    J Immunol; 1990 Mar; 144(6):2211-5. PubMed ID: 1968925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
    Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
    J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class II molecules on monocytes regulate T cell proliferation through physical interaction in the CD3 activation pathway.
    Ruggiero G; Racioppi L; Manzo C; Pirozzi G; D'Oro U; Ferrone S; Zappacosta S; Fontana S
    Eur J Immunol; 1991 Jan; 21(1):29-33. PubMed ID: 1825060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL; Kung JT
    J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
    Wasik MA; Morimoto C
    J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
    J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM; Sung SS; Hansen JA; Fu SM
    Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway.
    Karmann K; Hughes CC; Fanslow WC; Pober JS
    Eur J Immunol; 1996 Mar; 26(3):610-7. PubMed ID: 8605928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
    Walker C; Bettens F; Pichler WJ
    Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
    Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40 ligand is expressed and functional on activated neonatal T cells.
    Splawski JB; Nishioka J; Nishioka Y; Lipsky PE
    J Immunol; 1996 Jan; 156(1):119-27. PubMed ID: 8598451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
    Johnson-Léger C; Christenson JR; Holman M; Klaus GG
    J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes.
    Damle NK; Doyle LV; Grosmaire LS; Ledbetter JA
    J Immunol; 1988 Mar; 140(6):1753-61. PubMed ID: 2964482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.